Esra Güzel
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Rehabilitation top 10%
Papers in
-
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 8
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 4
- Co-authors
- Mustafa Özen (12 shared papers)Ömer Faruk Karataş (11 shared papers)Chad J. Creighton (7 shared papers)Michael Ittmann (7 shared papers)Mehmet Buğrahan Düz (3 shared papers)Mehmet Yılmaz (2 shared papers)Işın Doğan Ekici (2 shared papers)Mustafa Solak (2 shared papers)
- Journals
- The Prostate (3 papers)PLoS ONE (2 papers)Brazilian Archives of Biology and Technology (2 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)Pancreas (1 paper)
- Partner nations
- TürkiyeUnited StatesAntigua and Barbuda
In The Last Decade
Esra Güzel
32 papers receiving 658 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 354
- Rehabilitation 34
- Molecular Biology 371
- Periodontics 18
- Oncology 74
Countries citing papers authored by Esra Güzel
This map shows the geographic impact of Esra Güzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esra Güzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esra Güzel more than expected).
Fields of papers citing papers by Esra Güzel
This network shows the impact of papers produced by Esra Güzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esra Güzel. The network helps show where Esra Güzel may publish in the future.
Co-authors
The 25 scholars most cited alongside Esra Güzel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 89 | |
| 2 | 2015 | 81 | |
| 3 | 2019 | 74 | |
| 4 | 2014 | 67 | |
| 5 | 2004 | 53 | |
| 6 | 2014 | 44 | |
| 7 | 2014 | 44 | |
| 8 | 2015 | 36 | |
| 9 | 2006 | 35 | |
| 10 | 2018 | 29 | |
| 11 | 2015 | 29 | |
| 12 | 2016 | 18 | |
| 13 | 2020 | 14 | |
| 14 | 2021 | 12 | |
| 15 | 2020 | 8 | |
| 16 | 2013 | 6 | |
| 17 | 2022 | 4 | |
| 18 | 2015 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2023 | 3 |
About Esra Güzel
Esra Güzel is a scholar working on Cancer Research, Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine and Oncology, having authored 34 papers that have together received 672 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (5 papers), RNA modifications and cancer (4 papers), Drug Transport and Resistance Mechanisms (2 papers), Pancreatitis Pathology and Treatment (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Wound Healing and Treatments (1 paper). The work is most often cited by research in Cancer Research (354 citations), Rehabilitation (34 citations), Molecular Biology (371 citations), Periodontics (18 citations) and Oncology (74 citations). Esra Güzel has collaborated with scholars based in Türkiye, United States and Antigua and Barbuda. Frequent co-authors include Mustafa Özen, Ömer Faruk Karataş, Chad J. Creighton, Michael Ittmann, Mehmet Buğrahan Düz, Mehmet Yılmaz, Işın Doğan Ekici, Mustafa Solak, Serap Arbak and Nermina Jahovic. Their work appears in journals such as The Prostate, PLoS ONE, Brazilian Archives of Biology and Technology, Naunyn-Schmiedeberg s Archives of Pharmacology and Pancreas.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.